Skip to main content

Table 1 Ten patients diagnosed with P. vivax infection were recruited in the study from two malaria clinics in Thailand: Ubon Ratchathani and Yala

From: Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)

Sample

Age (years)

Gender

Province

Days of patency

Parasitaemia (parasites/200 leukocytes)

Patient group

UBT3086

50

Male

Ubon Ratchathani

2

220

1

UBT3087

NR

NR

Ubon Ratchathani

3

152

2

UBT3089

41

Male

Ubon Ratchathani

2

60

2

UBT3090

14

Male

Ubon Ratchathani

2

226

2

UBT3091

37

Male

Ubon Ratchathani

3

383

1

YL3111

26

Female

Yala

2

360

3

YL3112

45

Male

Yala

2

20

3

YL3113

15

Male

Yala

7

160

4

YL3114

30

Female

Yala

2

40

3

YL3115

46

Female

Yala

7

360

4

  1. Patients ranged between 14 and 50 years of age. Information regarding days of patency was provided by patients to medical officers during their visit
  2. NR not recorded
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us